Annual Total Liabilities
$170.18 M
+$5.94 M+3.62%
31 December 2023
Summary:
Poseida Therapeutics annual total liabilities is currently $170.18 million, with the most recent change of +$5.94 million (+3.62%) on 31 December 2023. During the last 3 years, it has risen by +$60.67 million (+55.40%). PSTX annual total liabilities is now -42.60% below its all-time high of $296.51 million, reached on 31 December 2019.PSTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$206.37 M
-$31.50 M-13.24%
30 September 2024
Summary:
Poseida Therapeutics quarterly total liabilities is currently $206.37 million, with the most recent change of -$31.50 million (-13.24%) on 30 September 2024. Over the past year, it has increased by +$27.77 million (+15.55%). PSTX quarterly total liabilities is now -52.19% below its all-time high of $431.65 million, reached on 30 June 2020.PSTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.6% | +15.6% |
| 3 y3 years | +55.4% | +84.6% |
| 5 y5 years | +39.7% | - |
PSTX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +55.4% | -13.2% | +84.6% |
| 5 y | 5 years | -42.6% | +55.4% | -52.2% | +95.0% |
| alltime | all time | -42.6% | +188.5% | -52.2% | +95.0% |
Poseida Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $206.37 M(-13.2%) |
| June 2024 | - | $237.87 M(+33.6%) |
| Mar 2024 | - | $177.99 M(+4.6%) |
| Dec 2023 | $170.18 M(+3.6%) | $170.18 M(-4.7%) |
| Sept 2023 | - | $178.59 M(+22.4%) |
| June 2023 | - | $145.91 M(-6.5%) |
| Mar 2023 | - | $156.06 M(-5.0%) |
| Dec 2022 | $164.24 M(+45.2%) | $164.24 M(+0.0%) |
| Sept 2022 | - | $164.17 M(+17.6%) |
| June 2022 | - | $139.66 M(-3.3%) |
| Mar 2022 | - | $144.45 M(+27.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $113.10 M(+3.3%) | $113.10 M(+1.2%) |
| Sept 2021 | - | $111.78 M(-0.7%) |
| June 2021 | - | $112.53 M(+6.3%) |
| Mar 2021 | - | $105.85 M(-3.3%) |
| Dec 2020 | $109.52 M(-63.1%) | $109.52 M(+0.2%) |
| Sept 2020 | - | $109.33 M(-74.7%) |
| June 2020 | - | $431.65 M(+295.1%) |
| Mar 2020 | - | $109.26 M(-63.2%) |
| Dec 2019 | $296.51 M(+143.4%) | $296.51 M |
| Dec 2018 | $121.84 M(+106.5%) | - |
| Dec 2017 | $59.00 M | - |
FAQ
- What is Poseida Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Poseida Therapeutics?
- What is Poseida Therapeutics annual total liabilities year-on-year change?
- What is Poseida Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly total liabilities year-on-year change?
What is Poseida Therapeutics annual total liabilities?
The current annual total liabilities of PSTX is $170.18 M
What is the all time high annual total liabilities for Poseida Therapeutics?
Poseida Therapeutics all-time high annual total liabilities is $296.51 M
What is Poseida Therapeutics annual total liabilities year-on-year change?
Over the past year, PSTX annual total liabilities has changed by +$5.94 M (+3.62%)
What is Poseida Therapeutics quarterly total liabilities?
The current quarterly total liabilities of PSTX is $206.37 M
What is the all time high quarterly total liabilities for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly total liabilities is $431.65 M
What is Poseida Therapeutics quarterly total liabilities year-on-year change?
Over the past year, PSTX quarterly total liabilities has changed by +$27.77 M (+15.55%)